The International Journal of Biotechnology, Genomics & Life Sciences
Timely dispatches on breakthrough peer-reviewed studies, clinical pipeline readouts, regulatory decisions from the FDA and EMA, and global biotech financing rounds.
First in-vivo CRISPR prime editing therapy cleared for sickle cell & beta-thalassemia IND
Helix Therapeutics closes $185M Series B for de novo antibody generation platform
AlphaProteome predicts dynamic allosteric pocket transitions at 0.78Å atomic resolution
EMA issues priority PRIME designation for synthetic mRNA organ fibrosis candidate
Regulatory authorization allows clinical investigators to initiate Phase I/II ascending-dose trials using engineered LNP delivery vectors without requiring ex-vivo bone marrow stem cell harvesting.
The guidance establishes international 28-day culture boundaries for synthetic human blastoids while preserving research exemptions for micro-electrode cortical organoids.
Concomitant myostatin receptor antagonism preserved 89% of baseline lean skeletal muscle mass during rapid adipose tissue reduction in a 740-patient randomized cohort.
Field biologists confirm lab-evolved Symbiodiniaceae micro-inoculations sustained photosynthetic electron transport despite surface water temperatures reaching 33.8°C.
Time-resolved electron microscopy reveals how 40 auxiliary chaperone proteins prevent premature rRNA misfolding during high-speed eukaryotic translation.
The financing will expand acoustic droplet liquid handling workcells in Basel, designed to test 10,000 deep-learning designed macrocyclic peptides per week.
Controlled 72-hour induction of Oct4, Sox2, and Klf4 restored endothelial nitric oxide synthase expression without teratoma formation or cellular dedifferentiation.
Regulatory approval eliminates legacy novel food classification bottlenecks for recombinant bovine whey and casein produced by Pichia pastoris fermentation.
Get weekly biology stories, research updates, and expert insights in your inbox.